Alphabetic Index FY2027

E34.39

Other short stature due to endocrine disorder

FY2027Chapter 4: Endocrine, nutritional and metabolic diseases/E20–E35 Disorders of other endocrine glands

BillableComplete code, valid to report
Care settingsHome Health Primary · MMTA - EndocrineIRF 60% Rule

E34.39 (also written E3439) is a billable ICD-10-CM diagnosis code for other short stature due to endocrine disorder. It is part of the FY2027 code set, effective October 1, 2026. It is one of the 18 codes in category E34 (Other endocrine disorders). The Alphabetic Index lists it under 1 entry. Its coding notes include 15 Excludes1 entries.

Excludes1

Not coded here. The listed conditions generally should not be reported together.

Inherited from E34.3 Short stature due to endocrine disorder
  • achondroplastic short stature (Q77.4)
  • hypochondroplastic short stature (Q77.4)
  • nutritional short stature (E45)
  • pituitary short stature (E23.0)
  • progeria (E34.8)
  • renal short stature (N25.0)
  • Russell-Silver syndrome (Q87.19)
  • short-limbed stature with immunodeficiency (D82.2)
  • short stature (child) (R62.52)
  • short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
  • short stature NOS (R62.52)
Inherited from E34 Other endocrine disorders
  • pseudohypoparathyroidism (E20.1)
Also from chapter/block level (3 notes)
Inherited from E20–E35 Disorders of other endocrine glands
Inherited from Chapter 4 Endocrine, nutritional and metabolic diseases
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Care settings

How CMS programs treat this code. These are CMS claim edits and list entries, not coverage or eligibility rules.

Home Health Primary

Accepted as the primary (principal) diagnosis on a home health claim. The Home Health Grouper assigns it to the MMTA - Endocrine clinical group.

Source: CMS Home Health Grouper Software v07.2.26, effective October 1, 2026

IRF 60% Rule

On the CMS list of diagnoses used to determine presumptive compliance with the IRF 60 percent rule.

Source: CMS IRF Presumptive Compliance-3, FY 2027 IRF PPS final rule files, effective for discharges on or after October 1, 2026

Notes

Also from chapter/block level (1 note)
Inherited from Chapter 4 Endocrine, nutritional and metabolic diseases
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Alphabetic Index terms

Terms the official Alphabetic Index lists for this code. 1 entry